Evaluation of the first clinical posting in psychiatry of the competency-based medical education (CBME) curriculum
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2021 - 2023
Project Lead
Salazar Luke Joshua
Authors
Salazar Luke Joshua, Priya Sreedaran, Uttara Chari, Bhuvaneshwari Sethuraman, Shalini Perugu
Project Status
completed